SLA 1.12% $4.50 silk laser australia limited

annual report, page-11

  1. 4,460 Posts.
    3."likely registration of BioA as a pharmaceutical to treat gastro (affecting 50% of the WORLDS population)"

    This has me intrigued, I am wondering on timelines for this and if any other trials needed. hmmmmm If only I were a pine beetle in a pine forest, to buy more or just sit is the question that boggles me for now?
 
watchlist Created with Sketch. Add SLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.